
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES207
This study found that there was a significant decrease in proteinuria with aspirin (15.9%),with dipyridamole (14.8%) and with the combination of aspirin and dipyridamole (37.3%)
compared with an increase in proteinuria found with placebo (1.9%), p=0.0007. Significantdecreases were also identified in the urinary protein/creatinine ratio with the three treatmentgroups compared with the placebo.There were no changes identified in BP, renal function tests and blood sugar. No adverse events(AEs) were noted during this study. Level 1+

[@Sacco_2003]

